New leprosy diagnostic test developed in Brazil

The NAT-HANS Kit has already been registered with Anvisa, responsible for regulating and approving products and services subject to health regulations for marketing and production in Brazil.

RIO DE JANEIRO, BRAZIL - Brazilian scientists announced the development of a new test for the diagnosis of Hansen's disease (leprosy), which has a worldwide prevalence of 22.9 persons per million inhabitants and is considered by the World Health Organization (W.H.O.) as a neglected tropical disease. India, Brazil, and Indonesia account for 79 percent of the world's cases.

The new method proposed for detecting the bacillus Mycobacterium leprae, which causes the disease, is the same method used in one of the Covid-19 diagnostic tests, PCR (Polymerase Chain Reaction).

Read also: Subscribe to our Premium Membership Plan. Already Subscribed?